Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 37, Status: Authorised
Highlights - 21st industry stakeholder platform - operation of European Union (EU) pharmacovigilance
Agenda of the COMP Meeting 3-5 November 2026
Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Organisation chart: Task Forces
Agenda of the CVMP meeting 3-5 November 2026
Nitrosamine Implementation Oversight Group Terms of Reference
Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages
QRD Appendix V - Adverse-drug-reaction reporting details